Kane Biotech Inc. (KNE.V) TSXV

0.05

-0.005(-10.00%)

Updated at September 29 02:34PM

Currency In CAD

Kane Biotech Inc.

Address

290-100 Innovation Drive

Winnipeg, MB R3T 6G2

Canada

Phone

204 453 1301

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

First IPO Date

October 01, 2003

Key Executives

NameTitlePayYear Born
Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNCInterim Chief Executive Officer, Executive Chairman & Member of Scientific Advisory Board01965
Mr. Ray DupuisChief Financial Officer161,686N/A
Ms. Lori ChristofalosChief Quality Officer0N/A
Nicole SendeyInvestor Relations Adviser0N/A
Ms. Wendy NachtigallDirector of Marketing0N/A
Lorne GorberInvestor Relations0N/A
Dr. Gregory S. Schultz Ph.D.Chief Scientific Officer & Member of Scientific Advisory Board01950

Description

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.